Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial - Kavanaugh, A; Puig, L; Gottlieb, A B (Arthritis Care Res (Hoboken), 2015)
et al.